Peginterferon-α_2a in the treatment of chronic hepatitis C

Author： Akimov Sergey Adeyemi Oluwatoyin M

ISSN： 1746-0794

Source： Future Virology, Vol.1, Iss.6, 2006-11, pp. : 689-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegylated Interferons for the Treatment of Chronic Hepatitis C: Pharmacological and Clinical Differences between Peginterferon-α-2a and Peginterferon-α-2b

By Foster Graham R.

Drugs, Vol. 70, Iss. 2, 2010-01 ,pp. : 147-165

Adis International

Access to resources Recommend Favorite

Peginterferon-α_2a (40 kDa) for chronic hepatitis C

By Hadziyannis Stephanos J Papatheodoridis George V

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 541-551

Informa Healthcare

Access to resources Recommend Favorite

Peginterferon-α-2a + ribavirin: shorter treatment duration inferior in hepatitis C

Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Peginterferon-α_2a for the treatment of hepatitis B infection

By Cooksley W Graham E

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1373-1380

Informa Healthcare

Access to resources Recommend Favorite

Peginterferon-α-2b: Autoimmune hepatitis in a patient with chronic hepatitis C virus and HIV infections: case report

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite